Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — September 2023

Genmab — September 2023

Planlagt Fastgjort Låst Flyttet Genmab
781 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #148

    Tivdak success could make life even harder for Iovance https://www.oncologypipeline.com/apexonco/tivdak-success-could-make-life-even-harder-iovance

    1 Reply Last reply
    0
    • K Offline
      K Offline
      Klarussen
      wrote on sidst redigeret af
      #149

      Dejligt

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #150

        HC Wainwright reaffirmed their buy rating on shares of Genmab A/S (NASDAQ:GMAB – Free Report) in a research report released on Tuesday, Benzinga reports. The firm currently has a $51.00 target price on the stock.

        1 Reply Last reply
        0
        • K Offline
          K Offline
          Klarussen
          wrote on sidst redigeret af
          #151

          sv.t. 3545 DKK for den danske aktie.

          1 Reply Last reply
          0
          • J Offline
            J Offline
            JKY_VH
            wrote on sidst redigeret af
            #152

            dejligt, tak for den;-)

            1 Reply Last reply
            0
            • SolsenS Offline
              SolsenS Offline
              Solsen
              wrote on sidst redigeret af
              #153

              Noget spændende på vej mht Amivantamab https://www.linkedin.com/posts/peter-lebowitz_mycompany-oncology-cancerresearch-activity-7105166416957333504-Atyt?utm_source=share&utm_medium=member_ios

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #154

                great, so after the BLA based on PAPILLON we may get another one based on MARIPOSA . hard to keep up with all these
                by the way...

                1 Reply Last reply
                0
                • BulderB Offline
                  BulderB Offline
                  Bulder
                  wrote on sidst redigeret af
                  #155

                  Rybrevant Mariposa-2 https://www.oncologypipeline.com/apexonco/mariposa-2-might-give-jj-confidence-lazertinib

                  1 Reply Last reply
                  0
                  • BulderB Offline
                    BulderB Offline
                    Bulder
                    wrote on sidst redigeret af
                    #156

                    Tagrisso er åbenbart late breaker -Flaura2 - på world lung denne week end. Mariposa 2 må så komme senere.

                    1 Reply Last reply
                    0
                    • BulderB Offline
                      BulderB Offline
                      Bulder
                      wrote on sidst redigeret af
                      #157

                      Jnj hævder jo at Rybrevant vil peake i >5 mia$, så med 8-10% royalty bliver det en stor post.

                      1 Reply Last reply
                      0
                      • BulderB Offline
                        BulderB Offline
                        Bulder
                        wrote on sidst redigeret af
                        #158

                        De er gode til at tease. Tivdak var topline positiv på overlevelse. Men data kender vi ikke. Rybrevant var i Mariposa 2 positiv på pfs, men data kender vi ikke.

                        1 Reply Last reply
                        0
                        • Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktør
                          wrote on sidst redigeret af
                          #159

                          Godmorgen 🙂

                          1 Reply Last reply
                          0
                          • S Offline
                            S Offline
                            Stroka
                            wrote on sidst redigeret af
                            #160

                            God morgen 🙂

                            1 Reply Last reply
                            0
                            • K Offline
                              K Offline
                              Klarussen
                              wrote on sidst redigeret af
                              #161

                              Short-% på Genmab øges, nu 0,75%. Den var længe 0,43% men øges langsomt

                              1 Reply Last reply
                              0
                              • B Offline
                                B Offline
                                bibob
                                wrote on sidst redigeret af
                                #162

                                God morgen. 🙂

                                1 Reply Last reply
                                0
                                • R Offline
                                  R Offline
                                  Riis7
                                  wrote on sidst redigeret af
                                  #163

                                  Shorter elsker og short biotek , se bare med Bava 🙂 men heldigvis har Genmab haft mere held med deres forsøg

                                  1 Reply Last reply
                                  0
                                  • StockBullS Offline
                                    StockBullS Offline
                                    StockBull
                                    wrote on sidst redigeret af
                                    #164

                                    Tror nærmere det er dygtighed end held. Personligt ville jeg ikke investere i en virksomhed som hovedsagligt er baseret på held. Dog enig i at jo mere heldig man er jo mere tjener man

                                    1 Reply Last reply
                                    0
                                    • StockBullS Offline
                                      StockBullS Offline
                                      StockBull
                                      wrote on sidst redigeret af
                                      #165

                                      Jo flere forsøg Genmab laver jo større chance for held. Jo hårdere Jans folk knokler desto heldigere vil de nok være

                                      1 Reply Last reply
                                      0
                                      • StockBullS Offline
                                        StockBullS Offline
                                        StockBull
                                        wrote on sidst redigeret af
                                        #166

                                        Manchester United har under Alex Ferguson scoret 166 mål i sidste minnut og mang journalister kalder ham heldig. Hans svar var at jo hårdere hans folk knoklede jo heldigere blev de

                                        1 Reply Last reply
                                        0
                                        • StockBullS Offline
                                          StockBullS Offline
                                          StockBull
                                          wrote on sidst redigeret af
                                          #167

                                          Så vi kan konkludere at Bava nok bare skal konkle noget mere

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper